Please assess the completion status of the following clinical trial:

Trial Title: Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or more~* macular edema associated with a 1 or type 2 diabetes with a hemoglobin A1C level over 5.5% and under \<13%~* indication for a treatment with intra-vitreal injections of ranibizumab~Exclusion Criteria:~* treatment with anti-VEGF during the previous 2 months~* treatment by intra-vitreous implant of dexamethasone during the previous six months~* previous history of vitrectomy or glaucoma~* photocoagulation during the previous 3 months~* patient's opposition to participate to the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Micropulsed laser photocoagulation (Type: EXPERIMENTAL): None
- Sham micropulsed laser photocoagulation (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).